Arkolith/Insider Trading/TBPH/Form 4

Miller Aine

SVP, DEV & HEAD OF IRE OFFICETheravance Biopharma, Inc. (TBPH) · full profile →Form 4 · filed May 21, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2025Tax withholding(F)10K$9.45$92K215K
May 19, 2025Grant(A)10K—$0225K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-014025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML